Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer

Hye-Jin KIM; Jin-Soo KIM; Myung-Deok SEO; So-Yeon OH; Do-Youn OH; Jee-Hyun KIM; Se-Hoon LEE; Dong-Wan KIM; Seock-Ah IM; Tae-You KIM; Dae-Seog HEO; Yung-Jue BANG.
Cancer Research and Treatment ; : 81-86, 2008.
Artículo en Inglés | WPRIM | ID: wpr-109497

Documentos relacionados

  1. Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial.
  2. Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes.
  3. Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients.
  4. Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.
  5. Dexamethasone dose-dependently prevents taxane-associated acute pain syndrome in breast cancer treatment.
  6. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines.
  7. Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis.
  8. The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study.
  9. Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial.
  10. Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial.